OTC · CIK 0000087802
SCND SCIENTIFIC INDUSTRIES INC
Insider trading from SEC Form 4. Last filing 35 d ago. Close $0.68 on Oct 12, 2026, +47% from the 52-week low and -22% from the high.
In brief
SCIENTIFIC INDUSTRIES INC (SCND) has 31 SEC Form 4 filings on file from 7 insiders, the latest filed on Sep 8, 2026. In the last 90 days insiders made 2 open-market buys worth $14k and 0 open-market sells worth $0, net +$14k.
16 open-market trades have been scored at SCND. The newest: John A Moore (Chairman of the Board) bought $3,800 of stock on Aug 20, 2026, filed Sep 8, 2026, scored 15 (weak). The largest of the 16 shown: Bleichroeder LP (10% owner) bought $1.2M on Dec 13, 2023, scored 50 (moderate). 4 insiders bought within 14 days of each other around Apr 18, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at SCIENTIFIC INDUSTRIES INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | John A Moore Chairman of the Board buy | $3,800 5,000 shares | +1% | +64% from low-10% from high | |
| 20Weak | John A Moore Chairman of the Board buy | $10k 14,700 shares | +2% | +64% from low-10% from high | |
| 24Weak | John A Moore Chairman of the Board buy | $2,845 4,000 shares | +0% | +66% from low-15% from high | |
| 28Weak | John A Moore Chairman buy | $5,220 9,000 shares | +1% | +29% from low-46% from high | |
| 28Weak | John A Moore Chairman of the Board buy | $650 1,000 shares | +0% | +44% from low-46% from high | |
| 33Weak | John A Moore Chairman buy | $6,359 11,700 shares | +2% | +33% from low-50% from high | |
| 28Weak | John A Moore Chairman buy | $3,455 6,500 shares | +1% | +33% from low-50% from high | |
| 33Weak | John A Moore Chairman buy | $12k 20,000 shares | +3% | +48% from low-44% from high | |
| 23Weak | John A Moore Chairman of the Board buy | $6,143 9,599 shares | +2% | +42% from low-50% from high | |
| 33Weak | John A Moore Chairman of the Board buy | $4,060 5,800 shares | +1% | +56% from low-46% from high | |
| 46Moderate | Michael Blechman director buy | $10k 10,000 shares | - | +32% from low-30% from high | |
| 55Moderate | John A Moore Chairman of the Board buy | $35k 35,000 shares | +33% | +32% from low-30% from high | |
| 48Moderate | John J Nicols director buy | $15k 15,000 shares | +100% | +32% from low-30% from high | |
| 49Moderate | Bleichroeder LP owner buy | $250k 250,000 shares | +21% | +32% from low-30% from high | |
| 20Weak | John A Moore Chairman of the Board buy | $6,755 7,000 shares | +1% | - | |
| 50Moderate | Bleichroeder LP owner buy | $1.2M 600,000 shares | +99% | +17% from low-56% from high |
Transactions
Every row filed, 43 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +5,000 | $0.76 | $3,800 | 950,641 | 35 d ago |
| Aug 20, 2026 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +14,700 | $0.71 | $10k | 945,641 | Aug 20, 2026 |
| Jun 2, 2026 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +4,000 | $0.71 | $2,845 | 930,871 | Jun 18, 2026 |
| Feb 17, 2026 | Helena R Santos President and CEO | AGrant or award Stock Optionderivative | +50,000 | - | - | 433,388 | Apr 1, 2026 |
| Feb 17, 2026 | Helena R Santos President and CEO | AGrant or award Stock Optionderivative | +130,000 | $0.00 | $0 | 563,388 | Apr 1, 2026 |
| Mar 23, 2026 | John A Moore Chairman | POpen-market purchase Common Stock | +9,000 | $0.58 | $5,220 | 926,871 | Mar 24, 2026 |
| Feb 19, 2026 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +1,000 | $0.65 | $650 | 917,871 | Mar 17, 2026 |
| Feb 17, 2026 | Michael Blechman director | AGrant or award Stock Optionderivative | +24,000 | $0.00 | $0 | 96,186 | Mar 17, 2026 |
| Feb 17, 2026 | John A Moore Chairman of the Board | AGrant or award Stock Optionderivative | +230,000 | $0.00 | $0 | 886,871 | Mar 17, 2026 |
| Feb 17, 2026 | John J Nicols director | AGrant or award Stock Optionderivative | +120,000 | $0.00 | $0 | 255,778 | Mar 17, 2026 |
| Feb 17, 2026 | Zachary Rovinsky Chief Financial Officer | AGrant or award Stock Optionderivative | +25,000 | $0.00 | $0 | 45,000 | Mar 17, 2026 |
| Feb 17, 2026 | Michael Blechman director | AGrant or award Stock Optionderivative | +20,000 | $0.00 | $0 | 116,186 | Mar 17, 2026 |
| Feb 17, 2026 | John A Moore Chairman of the Board | AGrant or award Stock Optionderivative | +30,000 | $0.00 | $0 | 916,871 | Mar 17, 2026 |
| Feb 17, 2026 | John J Nicols director | AGrant or award Stock Optionderivative | +20,000 | $0.00 | $0 | 275,778 | Mar 17, 2026 |
| Dec 17, 2025 | John A Moore Chairman | POpen-market purchase Common Stock | +11,700 | $0.54 | $6,359 | 656,871 | Dec 18, 2025 |
| Dec 17, 2025 | John A Moore Chairman | POpen-market purchase Common Stock | +6,500 | $0.53 | $3,455 | 663,371 | Dec 18, 2025 |
| Dec 5, 2025 | John A Moore Chairman | POpen-market purchase Common Stock | +20,000 | $0.60 | $12k | 645,171 | Dec 15, 2025 |
| Aug 20, 2025 | John J Nicols director | AGrant or award Common Stock | +15,000 | $1.00 | $15k | 90,778 | Oct 6, 2025 |
| Sep 17, 2025 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +5,800 | $0.70 | $4,060 | 467,089 | Sep 18, 2025 |
| Sep 16, 2025 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +9,599 | $0.64 | $6,143 | 461,289 | Sep 18, 2025 |
| Aug 20, 2025 | Michael Blechman director | AGrant or award Common Stock | +10,000 | $1.00 | $10k | 47,186 | Sep 9, 2025 |
| Aug 20, 2025 | John A Moore Chairman of the Board | AGrant or award Common Stock | +30,000 | $1.00 | $30k | 451,690 | Sep 4, 2025 |
| May 13, 2025 | Helena R Santos Chief Executive Officer | AGrant or award Stock Optionderivative | +70,000 | $0.00 | $0 | 359,443 | May 23, 2025 |
| May 13, 2025 | John A Moore Chairman of the Board | AGrant or award Stock Optionderivative | +65,000 | $0.00 | $0 | 451,690 | May 22, 2025 |
| Apr 18, 2025 | Michael Blechman director | POpen-market purchase Common Stock | +10,000 | $1.00 | $10k | 10,000 | May 19, 2025 |
| Apr 18, 2025 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +35,000 | $1.00 | $35k | 139,782 | May 19, 2025 |
| Apr 18, 2025 | Michael Blechman director | POpen-market purchase Warrants to Purchase Common Stockderivative | +10,000 | - | - | 47,186 | May 19, 2025 |
| Apr 18, 2025 | John A Moore Chairman of the Board | POpen-market purchase Warrant to Purchase Common Stockderivative | +35,000 | - | - | 386,690 | May 19, 2025 |
| Apr 18, 2025 | John J Nicols director | POpen-market purchase Common Stock | +15,000 | $1.00 | $15k | 30,000 | May 15, 2025 |
| Apr 18, 2025 | John J Nicols director | POpen-market purchase Warrant to Purchase Common Stockderivative | +15,000 | - | - | 90,778 | May 15, 2025 |
| Apr 18, 2025 | Bleichroeder LP owner | POpen-market purchase Common Stockindirect: See footnote | +250,000 | $1.00 | $250k | 1,453,351 | Apr 22, 2025 |
| Apr 18, 2025 | Bleichroeder LP owner | POpen-market purchase Warrants to Purchase Common Stockderivativeindirect: See footnote | +250,000 | - | - | 250,000 | Apr 22, 2025 |
| Oct 31, 2024 | John A Moore Chairman of the Board | POpen-market purchase Common Stock | +7,000 | $0.97 | $6,755 | 479,772 | Oct 31, 2024 |
| Dec 13, 2023 | Helena R Santos President | AGrant or award Common Stock | +1,250 | $2.00 | $2,500 | 257,016 | Dec 29, 2023 |
| Dec 13, 2023 | Helena R Santos President | AGrant or award Warrantsderivative | +1,250 | $0.00 | $0 | 258,266 | Dec 29, 2023 |
| Dec 20, 2023 | Jurgen Walter Schumacher director | AGrant or award Common Stockindirect: Shareholder | +67,500 | $2.00 | $135k | 80,131 | Dec 28, 2023 |
| Dec 20, 2023 | Jurgen Walter Schumacher director | AGrant or award Warrantsderivativeindirect: Shareholder | +67,500 | $0.00 | $0 | 80,131 | Dec 28, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | POpen-market purchase Common Stockindirect: See footnote | +600,000 | $2.00 | $1.2M | 1,203,351 | Dec 15, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | JOther Warrants to Purchase Common Stockderivativeindirect: See footnote | -278,947 | - | - | 0 | Dec 15, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | JOther Warrants to Purchase Common Stockderivativeindirect: See footnote | +278,947 | - | - | 278,947 | Dec 15, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | JOther Warrants to Purchase Common Stockderivativeindirect: See footnote | -22,728 | - | - | 0 | Dec 15, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | JOther Warrants to Purchase Common Stockderivativeindirect: See footnote | +22,728 | - | - | 22,728 | Dec 15, 2023 |
| Dec 13, 2023 | Bleichroeder LP owner | POpen-market purchase Warrants to Purchase Common Stockderivativeindirect: See footnote | +960,000 | - | - | 960,000 | Dec 15, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Michael Blechmandirector
- Bleichroeder LPowner
- John A MooreChairman of the Board
- John J Nicolsdirector
- Zachary RovinskyChief Financial Officer
- Helena R SantosPresident
- Jurgen Walter Schumacherdirector
Questions about SCND
Answered from the filings on this page, as of the latest one.
Are insiders buying SCND?
As of Sep 8, 2026, SEC Form 4 filings show 2 open-market buys worth $14k by 1 insider and 0 open-market sells worth $0 by 0 insiders at SCIENTIFIC INDUSTRIES INC in the last 90 days, net +$14k. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade SCND on the open market?
John A Moore (Chairman of the Board) bought $3,800 of SCND on Aug 20, 2026 and filed the Form 4 on Sep 8, 2026. InsiderTell scored 15 (weak).
How many insiders file Form 4 at SCIENTIFIC INDUSTRIES INC?
7 people have filed a Form 4 at SCIENTIFIC INDUSTRIES INC, among them Michael Blechman (director), Bleichroeder LP (10% owner), John A Moore (Chairman of the Board). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.